R
RCE
RECCE PHARMACEUTICAL
0.480
+0.025+5.49%Closed16:10 04/10 AEST
OPEN/PREV CLOSE0.475/0.455
TODAY RANGE0.460-0.480
VOL124.25K
MARKET CAP138.81M
52 WEEK RANGE0.275-0.730
AVG VOL (3M)136.53K
% TURNOVER0.04%
TURNOVER57.86K
P/E (TTM)-4.2216
% RANGE4.40%
EPS(TTM)-0.1137
P/E(FORWARD)-6.5306
P/B-7.4534
BVPS-0.0644
DIVIDEND--
P/S17.98
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP79.20M
SHARES OUTSTANDING289.18M
NEXT EARNINGS07/29-08/03
FREE FLOAT164.99M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·04/01 00:00
corporate presentation april 2026 pdf
ASX·03/24 00:53
Brazil Patent Granted for RECCE Anti-Infectives
ASX·03/18 23:44
RCE Investor Webinar Presentation Deck
ASX·03/17 04:02
RCE Investor Webinar Presentation
ASX·03/02 00:00
corporate presentation
ASX·02/27 07:04
Appendix 4D and Interim Financial Report
ASX·02/24 06:53
Change of Director's Interest Notices (x5)
ASX·02/24 06:19
Notification of cessation of securities - RCE
ASX·02/01 22:00
Recce Enters Second U.S. Department of Defense R&D Agreement
ASX·01/30 02:02
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·01/13 23:39
AUD $5.3m R&D Rebate Received
ASX·01/05 00:00
corporate presentation
ASX·12/15/2025 22:51
RCE Awarded Advanced Overseas Finding up to A$85m
ASX·12/02/2025 00:00
corporate presentation
ASX·11/26/2025 23:07
Hong Kong Patent Granted for RECCE Anti-Infectives
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others